Stem cell hype: Join the conversation – HealthNewsReview.org
|
Stem cell hype: Join the conversation
HealthNewsReview.org If it had, it likely would have been about medical tourism. There would’ve been outrage directed at “third world” countries who allow unregulated and unproven stem cell “therapies” to be offered to desperate patients. Well, that concern is now closer … |
Triangle Business Journal |
Pfizer to invest $100M in NC for gene therapy
Burlington Times News SANFORD — Biopharmaceutical giant Pfizer Inc. plans to invest $100 million in a North Carolina plant to focus on a process by which genetic material is introduced to counter defective or missing genes. The company confirmed Gov. Roy Cooper’s news on … Pfizer investing $100M in Sanford plant expansion, adding jobsTriangle Business Journal |
|
Kite Pharma Submits IND for BCMA-Targeting CAR-T Cancer Immunotherapy
Genetic Engineering & Biotechnology News (press release) Kite Pharma said today it has submitted to the FDA an Investigational New Drug (IND) application to launch a Phase I, first-in-human trial of a chimeric antigen receptor T-cell (CAR-T) therapy that targets B-cell maturation antigen (BCMA) in patients … |
|
Stem cell transplantation and CMS: Extreme (hospital at) home makeover
Healio Stem cell transplantation and CMS: Extreme (hospital at) home makeover. HemOnc Today, August 10, 2017. John Sweetenham, MD. “It’s no wonder that truth is stranger than fiction. Fiction has to make sense.” – Mark Twain. The concept of “hospital at home” … |
|
Protea Announces Research Agreement with Mass General Hospital
Markets Insider MORGANTOWN, W. Va, Aug. 8, 2017 /PRNewswire/ — Protea Biosciences Group, Inc. (OTCQB: PRGB) (‘Protea’) announced today that it had entered into a … |